Beyond Meat Faces Investor Lawsuit Over Asset Valuation Claims
11.02.2026 - 06:21:04
The plant-based protein company Beyond Meat is confronting significant legal challenges as a class action lawsuit moves forward. The case centers on allegations that the firm made misleading statements regarding its financial health, specifically the valuation of certain assets.
Investors who purchased Beyond Meat securities between February 27 and November 11, 2025, have until March 24, 2026, to apply as lead plaintiffs in the proceedings. The suit, Aljendan v. Beyond Meat, Inc., was filed with the federal court in California on January 23, 2026.
The legal action alleges that Beyond Meat and certain executives failed to disclose or misrepresented crucial information during the class period. The plaintiffs contend that the company should have recognized an asset impairment charge of $77.4 million much earlier. Key accusations include:
* The carrying value of specific long-lived assets was overstated compared to their real worth.
* A substantial write-down was foreseeable based on the company's circumstances.
* These issues posed a risk to Beyond Meat's ability to file mandatory reports with the SEC in a timely manner.
The market reaction to the unfolding situation was severe. On October 24, 2025, Beyond Meat released preliminary third-quarter figures and announced an impending impairment charge, triggering a 23 percent collapse in its share price. A subsequent delay of the official quarterly filing on November 3, citing ongoing accounting reviews, wiped out an additional 16 percent of the stock's value.
Should investors sell immediately? Or is it worth buying Beyond Meat?
Financial Results Revealed
Beyond Meat officially presented its Q3 results on November 10, 2025. The report detailed an operating loss of $112.3 million, which incorporated the $77.4 million in impairment charges. These non-cash charges were related to property and equipment, operating lease right-of-use assets, and prepaid lease costs.
The legal process is in its early stages; no liability has been established, and the court has not yet certified the class action. This lawsuit adds to the pressures on Beyond Meat, which has been grappling with softening demand for plant-based meat alternatives for several months. The company's current market capitalization sits between $320 million and $420 million—a fraction of its valuation at its 2019 initial public offering.
The deadline for affected investors to seek lead plaintiff status is March 24, 2026.
Ad
Beyond Meat Stock: Buy or Sell?! New Beyond Meat Analysis from February 11 delivers the answer:
The latest Beyond Meat figures speak for themselves: Urgent action needed for Beyond Meat investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 11.
Beyond Meat: Buy or sell? Read more here...
